Stomatin-like protein 2 (STOML2 or SLP-2) is an oncogenic anti-apoptotic protein that is upregulated in several types of cancer, including cervical cancer. However, the mechanisms responsible for the SLP-2 anti-apoptotic function remain poorly understood. Here, we show that siRNA-mediated SLP-2 suppression decreases growth of human cervical cancer HELA and SIHA cells, and increases cisplatininduced apoptosis through activation of MEK/ERK signaling and suppression of the mitochondrial pathway. The inhibition of the mitochondrial pathway is mediated by increasing the mitochondrial Ca 2+ concentration and mitochondrial membrane potential, thereby downregulating p-MEK and p-ERK levels, upregulating the Bax/ Bcl-2 ratio, increasing cytochrome C release from mitochondria into the cytosol, and upregulating levels of cleaved-caspase 9, cleaved-caspase 3, and cleaved poly ADPribose polymerase (PARP). Overexpression of SLP-2 using adenovirus-STOML2 has the opposite effect: it upregulates p-MEK and p-ERK and downregulates the Bax/ Bcl-2 ratio and levels of cleaved-caspase 9 to caspase 9, cleaved-caspase 3 to caspase 3, and cleaved-PARP to PARP in cisplatin-treated cells. These data show that SLP-2 inhibits cisplatin-induced apoptosis by activating the MEK/ERK signaling and inhibiting the mitochondrial apoptosis pathway in cervical cancer cells. 
proliferation, tumorigenicity, and cell adhesion. Wang et al expanded the options for combining metabolic interventions with genotoxic chemotherapeutics by showing that SLP-2 coordinates bioenergetics and apoptosis. 13 A previous study reported that SLP-2 modulates mitochondrial calcium extrusion, thereby altering the ability of mitochondria to buffer calcium ion (Ca 2+ ) and shape cytosolic Ca 2+ signals. 14 In our previous study, we used siRNA to downregulate the expression of SLP-2, then TUNEL assay and annexin V assay were used to detect the apoptosis of HeLa and HCC94 cells by using cisplatin, which revealed that silencing SLP-2 expression significantly enhanced the sensitivity of cervical cancer cells to apoptosis induced by chemotherapeutics. 15 However, the mechanisms behind this inhibition of apoptosis by SLP-2 remain incompletely understood.
In this study, we investigated the function of SLP-2 in regulating apoptosis in human cervical cancer cells. We show that SLP-2 is upregulated by high cisplatin concentrations, leading to increased protein turnover. In addition, we show that overexpression of SLP-2
activates the MEK/ERK signaling pathway, and suppresses the mitochondrial apoptosis pathway, indicating that SLP-2 inhibits apoptosis by activating the MEK/ERK pathway and inhibiting the mitochondrial apoptosis pathway in cervical cancer cells.
| MATERIALS AND METHODS

| Cell culture
Cervical adenocarcinoma HELA cells were cultured in DMEM/high glucose and squamous cell carcinoma of the cervix SIHA cells were grown in RPMI-1640 medium supplemented with 10% FBS in a humidified incubator containing 5% CO 2 at 37°C. All culture reagents were purchased from Invitrogen (Carlsbad, CA, USA).
| Small interfering RNA transfection
The SLP-2 siRNA duplex (1.sense, 5 0 -GGACUCCAACACUAUCCUAtt-3 0 ; antisense, 3 0 -UAGGAUAGUGUUGGAGUCCtt-5 0 ; 2.sense, by quantitative real-time PCR (qRT-PCR) 24 hours after transfection using GAPDH for normalization, and by Western blot analysis 48 hours after transfection using a-tubulin for normalization.
| Adenovirus infection
Ad-STOML2 and Ad-GFP were purchased from ViGene (USA 
| RNA extraction and qRT-PCR
Total cellular RNA was extracted from cells using the TRIzol reagent (Invitrogen). Total RNA (1 lg) was reverse transcribed, and first-strand cDNA was synthesized using reverse transcriptase (Roche, Penzberg, Germany) according to the manufacturer's instructions. The resulting cDNA was used for qRT-PCR;
GAPDH was used as an internal control. For SLP-2, the 5 0 -primer was 5 0 -GTGACTCTCGACAATGTAAC-3 0 , and the 3 0 -primer was carried out at least three times, and statistical analyses was performed. Subsequently, membranes were incubated with primary antibodies at 4°C overnight. Following washing three times, the membranes were incubated with fluorescence-conjugated secondary antibodies at room temperature in the dark for 1 hour and visualized with Odyssey IR imaging system (LI-COR Biosciences). Normalization was ensured by a-tubulin, and each band was quantified using Quantity
| Western blot analysis
One software.
| Data and statistical analysis
Data were analyzed by two-tailed Student's t test or ANOVA, and are presented as the mean value AE SEM. Significant ANOVA were followed by Dunnett's multiple comparison post hoc test. 15 lg/mL, respectively) for 24 h and total protein was extracted to detect the expression of phosphorylated (Phospho)-MEK1/2, Phospho-ERK1/2, Bax, Bcl-2, caspase-9, cleaved caspase-9, caspase-3, cleaved caspase-3, PARP and cleaved-PARP by Western blot analysis. a-Tubulin was used as a loading control. B, C, E, F, Graphs represent densitometry of the results of three independent experiments (mean AE SEM). *P < .05; **P < .01; ***P < .001. siNC, non-targeting siRNA To confirm the apoptotic resistance effect of SLP-2, transfected HELA or SIHA cells were treated with IC 50 of cisplatin, and flow cytometric analysis was carried out using annexin V and PI. We found that annexin V + /PI À cells (early apoptosis) were more frequently detected in siSLP-2 transfected cells than in control cells ( Figure 3B,C,b,c) .
| Stomatin-like protein 2 is required for the stability of mitochondrial calcium ions and MMP
Calcium ion is a ubiquitous intracellular signal responsible for numerous cellular events, such as proliferation/growth, differentiation, apoptosis, and cell survival. Calcium ion overload in the mitochondria is one of the earliest intracellular events that occur following induction of apoptosis. After exposure of HELA and SIHA cells treated with siSLP-2 to IC 50 of cisplatin for 6 hours, the mitochondrial Ca 2+ concentration in HELA cells was increased to 230% AE 13% (Figure 3F ) of the control value, and in SIHA cells to 192% AE 18% (Figure 3f) . The mitochondrial Ca 2+ concentration in HELA cells treated with Ad-STOML2 followed by IC 50 of cisplatin for 6 hours decreased to 47% AE 9% ( Figure 3F ) of the control value, whereas in SIHA cells it decreased to 42% AE 9% (Figure 3f ). Mitochondrial and cytoplasmic proteins were respectively extracted to detect the expressions of cyt-C by Western blot analysis. a-Tubulin was used as a loading control of cytoplasmic proteins and VDAC1 as a loading control of mitochondrial proteins. B, C, E, F, Graphs represents densitometry of the results of three independent experiments (mean AE SEM). *P < .05; **P < .01; ***P < .001. SiNC, non-targeting siRNA SLP-2 in HELA and SIHA cells involves alterations of MMP, we used a JC-1 probe to monitor the change of MMP by flow cytometry.
After exposure to IC 50 of cisplatin for 6 hours, the MMP of HELA and SIHA cells treated with siSLP-2 was significantly increased relative to that of control (3.8% vs 17.9% in Figure 3D ,E; 3.2% vs 25.1%
in Figure 3d ,e). These data suggest that mitochondrial dysfunction might be involved in the process of IC 50 of cisplatin-induced apoptosis in HELA and SIHA cells because of the change of SLP-2 expression.
| Effect of SLP-2 on MEK/ERK signaling, and on the mitochondrial apoptosis pathway
As calcium channels have a very important role in the activation of RAF-MEK-ERK mitogen-activated protein kinase pathways, we examined the effect of SLP-2 on the activities of p-MEK1/2 and p-ERK1/2 kinases. We found that the levels of p-MEK1/2 and p-ERK1/2 correlated with the levels of SLP-2 in HELA ( Figure 4A,B) and SIHA ( Figure 4D ,E) cells. lg/mL, respectively) for 24 h and total protein was used to detect the expression of SLP-2, phosphorylated (P-)MEK1/2, P-ERK1/2, Bax, Bcl-2, caspase-9, cleaved caspase-9, caspase-3, cleaved caspase-3, PARP, and cleaved PARP by Western blot analysis. a-Tubulin was used as a loading control. E, F, e, f, Real-time quantitative PCR and Western blot analyses were carried out to measure the mRNA and protein expression of SLP-2. GAPDH and a-tubulin were used as loading controls. G, g, Graph represent densitometry of the results of three independent experiments (mean AE SEM). *P < .05; **P < .01; ***P < .001
F I G U R E 6
Bcl-2 and Bax are signaling proteins involved in the mitochondrial pathway of caspase 3-dependent apoptosis, which is associated with the release of cytochrome C (cyt-C) from the mitochondrial matrix to the cytoplasm. We found that HELA ( Figure 4A ,C) and SIHA ( Figure 4D ,F) cells overexpressing SLP-2 had a decreased ratio of Bax/Bcl-2, cleaved caspase-9/caspase 9, cleaved caspase-3/caspase-3 and cleaved poly ADP-ribose polymerase (PARP)/PARP and decreased levels of cyt-C released from mitochondria into cytosol ( Figure 5 ).
To analyze the role of MEK1/2, HELA and SIHA cells were treated for 24 hours with increasing concentrations of U0126, a highly selective inhibitor of MEK1/2, and p-MEK1/2 and p-ERK1/2 levels were analyzed by Western blotting. As shown in Figure 6 resulting in reduced tumor cell motility, proliferation, and ATP production. 13, 18 Upregulated SLP-2 can increase the expression of MMP-9, which are tightly involved in cancer development and progression. [19] [20] [21] [22] Suppression of SLP-2 inhibits the nuclear factor-jB (NF-jB) activity and expression of nuclear factor-jB-dependent genes, indicating that SLP-2 is involved in the modulation of apoptosis pathway.
| DISCUSSION
23-25
Stomatin-like protein 2 is upregulated under conditions of mitochondrial stress and interacts with prohibitins, chaperones in respiratory chain complexes, in the mitochondrial inner membrane. 3 The protein is required for stress-induced mitochondrial hyperfusion. 26 Upregulation of SLP-2 increases the mitochondrial membrane phospholipid cardiolipin, thus inducing mitochondrial biogenesis. 27 Moreover, SLP-2 deficiency is associated with impaired cardiolipin compartmentalization in mitochondrial membranes. 28 It has also been shown that SLP-2 negatively modulates mitochondrial sodium-calcium exchange. 14 14 Clearly, further investigation is needed to elucidate the function and regulation of SLP-2 in the pathogenesis of cervical cancer.
In this study, we found that SLP-2 suppression in HELA and SIHA cells decreased cell viability, and increased cisplatin-induced apoptosis, increased mitochondrial Ca 2+ concentration and loss of MMP, decreased p-MEK1/2 and p-ERK1/2 levels, increased cyt-C release from mitochondria into cytosol, and upregulated the ratio of Bax to Bcl-2, cleaved caspase-9 to caspase-9, cleaved caspase-3 to caspase-3, and cleaved PARP to PARP. Upregulation of SLP-2 in cisplatin-treated cells had the opposite effect. Changes of p-MEK1/2 and p-ERK1/2 had little effect on SLP-2 in cisplatin-induced apoptosis. Together, these data suggest that SLP-2 might affect MEK/ERK signaling through altering the ability of mitochondria to buffer Ca 2+ and shape cytosolic Ca 2+ signals, 14 and that overexpression of SLP-2 inhibits the mitochondrial apoptosis pathway.
Wang et al 13 reported that esophageal carcinoma cells showed enhanced apoptotic responses to cisplatin, adriamycin, or camptothecin in SLP-2-suppressed cells. We found that high cisplatin concentrations induce SLP-2 expression, which is in agreement with a previous study that suggested an anti-apoptotic role of SLP-2 in cells stressed with cycloheximide and UV irradiation. 26 High cisplatin concentrations also increased the p-MEK1/2 and p-ERK1/2 levels, and decreased the ratio of Bax/Bcl-2, cleaved caspase-9/caspase-9, 
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